News

news

News


Alimentiv’s model attracts eyes across the medical community and beyond. Here are the latest stories people are telling about us, our mission and our unique Health Trust.

Alimentiv Welcomes Mike Reffeitt As New Chief Financial Officer

Alimentiv is pleased to announce that Mike Reffeitt joined Alimentiv Inc. as the new Chief Financial Officer, effective Monday, May 3, 2021. Mike will be working alongside the executive team to drive the business and strategy of the Alimentiv group of companies forward and support our corporate operations teams including IT, legal, quality, facilities, and […]

read more

International Women’s Day And Our Alimentiv Leaders

International Women’s Day 2021 is on Monday, March 8th. Alimentiv is proud to celebrate this, honour the achievements of women across the globe, and continues to foster a culture where all employees and prospective candidates receive equal opportunities. Lisa Harrison, Chief Operating and Privacy Officer for Alimentiv took some time to discuss her growth and […]

read more

Implementation of Histopathology in GI Clinical Trials

Join our expert panel where they will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including Histopathology as a treatment target in IBD: Aspiration or Reality? Measuring histopathology in IBD trials Histopathology as a treatment target […]

read more

Facilitating Drug Development in Under-served Patient Populations

Development of a Radiological Index for Peri-anal Crohn’s Disease

read more

Optimal Biopsy Location for Biomarker Analyses

The appropriate location for biopsy sampling is a common question in gastrointestinal diseases such as Crohn’s disease (CD) and ulcerative colitis (UC). Standardization of biopsy procurement is essential during drug development to define response to therapy.

read more